| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/31/2011 | CA2775665A1 Turmeric pigment composition and method for preparing same |
| 03/31/2011 | CA2775404A1 Formulations comprising triptan compounds |
| 03/31/2011 | CA2775323A1 Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process |
| 03/31/2011 | CA2775293A1 Manufacture of lozenge product with radiofrequency |
| 03/31/2011 | CA2775227A1 Acid resistant capsules |
| 03/31/2011 | CA2775126A1 Manufacture of chewing gum product with radiofrequency |
| 03/31/2011 | CA2775079A1 Implant devices for modulating bioactive agent release profiles |
| 03/31/2011 | CA2775077A1 Implant devices having varying bioactive agent loading configurations |
| 03/31/2011 | CA2775054A1 Manufacture of tablet having immediate release region and sustained release region |
| 03/31/2011 | CA2775047A1 Manufacture of tablet in a die utilizing powder blend containing water-containing material |
| 03/31/2011 | CA2774968A1 Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder |
| 03/31/2011 | CA2774893A1 Antiseptic ointment comprising bentonite intercalated with silver, copper or zinc for external application |
| 03/31/2011 | CA2774750A1 Treatment and prevention of hiv infection |
| 03/31/2011 | CA2774616A1 Composition and method for treatment of diabetes |
| 03/31/2011 | CA2774153A1 Galenic form suitable for absorbing, in a specific manner, the undesirable molecules in the digestive tract |
| 03/31/2011 | CA2772795A1 Injectable aqueous ophthalmic composition and method of use therefor |
| 03/31/2011 | CA2772220A1 Eye drops |
| 03/31/2011 | CA2771831A1 Oral pharmaceutical composition comprising diclofenac |
| 03/30/2011 | EP2302059A1 Modifications of hiv Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 03/30/2011 | EP2301976A1 Water-soluble acrylic acid salt polymer and gelling base |
| 03/30/2011 | EP2301952A2 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 03/30/2011 | EP2301951A1 Peptide derivative and composition for promoting tear secretion comprising the same |
| 03/30/2011 | EP2301659A1 Microcapsules, method of producing the microcapsules and food and drink containing the microcapsules |
| 03/30/2011 | EP2301628A1 Methods and reagents for the treatment of immunoinflammatory disorders |
| 03/30/2011 | EP2301584A1 Methods and compositions for treatment of interferon-resistant tumors |
| 03/30/2011 | EP2301565A1 Use of proteasome inhibitors for the treatment of viral infections |
| 03/30/2011 | EP2301564A1 Compositions and methods for promoting neuronal outgrowth |
| 03/30/2011 | EP2301562A1 Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 03/30/2011 | EP2301556A1 Co-Administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer |
| 03/30/2011 | EP2301555A1 Cream-like o/w type emulsified composition and method for producing same |
| 03/30/2011 | EP2301549A1 Remedies for diseases to be applied to eye |
| 03/30/2011 | EP2301548A1 Stannsoporfin compositions and administration |
| 03/30/2011 | EP2301542A1 Controlled-release compositions containing opioid agonist and antagonist |
| 03/30/2011 | EP2301526A2 Morphine controlled release system |
| 03/30/2011 | EP2301525A1 Topical ibuprofen formulation |
| 03/30/2011 | EP2301524A1 Inhalable aztreonam without arginine for treatment and prevention of pulmonary bacterial infections |
| 03/30/2011 | EP2301523A1 Galenic formulation in colloidal form |
| 03/30/2011 | EP2301494A1 Sustained analgesia achieved with buprenorphine |
| 03/30/2011 | EP2301493A1 Sustained analgesia achieved with buprenorphine |
| 03/30/2011 | EP2300604A1 Nitric oxide compositions and devices and methods for cosmesis |
| 03/30/2011 | EP2300603A1 Nitric oxide device and method for wound healing, treatment of dermatological disorders and microbial infections |
| 03/30/2011 | EP2300067A2 Drug delivery composition |
| 03/30/2011 | EP2300056A2 Compliant composites for application of drug-eluting coatings to tissue surfaces |
| 03/30/2011 | EP2300031A2 Methods and compositions for oral administration of exenatide |
| 03/30/2011 | EP2300030A2 Rice bran extracts and methods of use thereof |
| 03/30/2011 | EP2300029A2 Rice bran extracts for inflammation and methods of use thereof |
| 03/30/2011 | EP2300018A1 Paeoniflorin preparations and uses thereof for fat reduction |
| 03/30/2011 | EP2299990A1 Novel embedment particles for inhalation |
| 03/30/2011 | EP2299989A2 Stabilized transdermal drug delivery system |
| 03/30/2011 | EP2299988A1 Silk polymer-based adenosine release: therapeutic potential for epilepsy |
| 03/30/2011 | EP2299987A1 Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative |
| 03/30/2011 | EP2299986A1 A chronotherapeutic pharmaceutical dosage form |
| 03/30/2011 | EP2299985A1 Diagnostic reagent, containing bioparticles, method for production thereof and use thereof as internal standard in nucleic acid preparation and nucleic acid detection methods |
| 03/30/2011 | EP2299984A1 Oral formulations of cytidine analogs and methods of use thereof |
| 03/30/2011 | EP2299983A1 Stabilized atypical antipsychotic formulation |
| 03/30/2011 | EP2299982A1 Directly injection moldable and rapidly disintegrating tablet matrix |
| 03/30/2011 | EP2299981A1 Sublingual compositions comprising (2s) - (4e) -n-methyl-5- (3- (5-isopropoxypyridin) yl) -4-penten-2-amine |
| 03/30/2011 | EP2299980A2 Silicon dioxide nanoparticles and their use for vaccination |
| 03/30/2011 | EP2299979A2 Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 03/30/2011 | EP2299978A1 Single dosage pharmaceutical formulation comprising eprosartan mesylate |
| 03/30/2011 | EP2299977A2 Liposomes for drug delivery and methods for preparation thereof |
| 03/30/2011 | EP2299976A2 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| 03/30/2011 | EP2299975A1 Preparation and iontophorectic device for the transdermal application of active ingredients |
| 03/30/2011 | EP2299974A1 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug |
| 03/30/2011 | EP2299973A1 Pharmaceutical preparation comprising permethylated cyclodextrin |
| 03/30/2011 | EP2299972A1 Topical compositions |
| 03/30/2011 | EP2299971A1 Solid pharmaceutical formulations comprising bibw 2992 |
| 03/30/2011 | EP2299970A2 Canker sore patch |
| 03/30/2011 | EP2299849A2 Fluid bed meal containing a marker and methods of making |
| 03/30/2011 | EP2299820A1 Ophthalmic formulation of rho kinase inhibitor compound |
| 03/30/2011 | EP2299810A1 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
| 03/30/2011 | EP2178513B1 Tableted compositions containing atazanavir |
| 03/30/2011 | EP2131823B1 Rapid-disintegration monolayer film for the oral administration of active substances |
| 03/30/2011 | EP2101729B1 Self-microemulsifying drug delivery systems |
| 03/30/2011 | EP2046140B1 Compositions of microparticles and granules for oral controlled release of substances for veterinary use |
| 03/30/2011 | EP2037899B1 Nanoparticles for nucleic acid delivery |
| 03/30/2011 | EP2037897B1 An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof |
| 03/30/2011 | EP1906920B1 Pharmaceutical composition for treating xerostomia |
| 03/30/2011 | EP1888039B1 Dustless powder materials |
| 03/30/2011 | EP1807046B1 Reverse micelles based on phytosterols and acylglycerols and therapeutic use thereof |
| 03/30/2011 | EP1804773B1 Loadable polyphosphazene-comprising particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
| 03/30/2011 | EP1663331B1 Implantable or insertable medical devices containing silicone copolymer for controlled delivery of therapeutic agents |
| 03/30/2011 | EP1592443B1 Improved anthrax vaccines and delivery methods |
| 03/30/2011 | EP1507515B1 Free-flowing, powdery composition containing alpha-liponic acid (-derivatives) |
| 03/30/2011 | EP1392381B1 An aerosol forming device for use in inhalation therapy |
| 03/30/2011 | EP1337242B1 Gene delivery formulations for treatment of ischemic conditions |
| 03/30/2011 | EP1305007B1 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 03/30/2011 | EP1053023B2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 03/30/2011 | CN201775804U Composite structure of drug for treating type 2 diabetes |
| 03/30/2011 | CN201775803U Plaster |
| 03/30/2011 | CN1968662B An absorbent article containing flavor |
| 03/30/2011 | CN1953741B Solid formulations of ospemifene |
| 03/30/2011 | CN1899316B Chinese medicine micro emulsion preparation and its preparing method |
| 03/30/2011 | CN1814040B Compound liquid capsule of Chinese caterpillar fungus and quality control method |
| 03/30/2011 | CN1496738B Fenofibrate medicine composition with high bio-availability and preparation method thereof |
| 03/30/2011 | CN101998859A Pharmaceutical composition for preventing dysbiosis associated with enteral administration of antibiotics |
| 03/30/2011 | CN101998858A Pharmaceutical composition of antibiotics and prebiotics for preventing and treating dysbiosis during antibacterial therapy |
| 03/30/2011 | CN101998857A Wet granulation using a water sequestering agent |
| 03/30/2011 | CN101998850A Process for recovering florfenicol from pharmaceutical compositions |
| 03/30/2011 | CN101993462A Scutellarin crystal I and preparation method thereof |